$0.11 Earnings Per Share Expected for Envista Holdings Corporation (NASDAQ:NVST) This Quarter

Equities research analysts expect Envista Holdings Corporation (NASDAQ:NVST) to announce earnings per share of $0.11 for the current quarter, Zacks reports. Six analysts have made estimates for Envista’s earnings, with the highest EPS estimate coming in at $0.23 and the lowest estimate coming in at ($0.14). The business is expected to announce its next earnings results on Tuesday, August 11th.

On average, analysts expect that Envista will report full year earnings of $0.23 per share for the current fiscal year, with EPS estimates ranging from ($0.02) to $0.56. For the next financial year, analysts forecast that the business will report earnings of $1.17 per share, with EPS estimates ranging from $0.56 to $1.51. Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that that provide coverage for Envista.

Envista (NASDAQ:NVST) last announced its quarterly earnings results on Tuesday, May 12th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.10 by ($0.07). The firm had revenue of $547.20 million during the quarter, compared to analyst estimates of $569.07 million. The company’s quarterly revenue was down 17.1% compared to the same quarter last year.

Several research analysts recently weighed in on the company. Zacks Investment Research upgraded Envista from a “strong sell” rating to a “hold” rating in a research note on Wednesday, April 15th. Piper Sandler initiated coverage on Envista in a research note on Tuesday, June 16th. They set a “neutral” rating and a $20.00 target price on the stock. Bank of America reaffirmed a “neutral” rating and set a $18.00 price target (down previously from $19.50) on shares of Envista in a research report on Wednesday, May 13th. Credit Suisse Group lowered their price target on Envista from $23.00 to $21.00 and set a “neutral” rating for the company in a research report on Wednesday, May 13th. Finally, JPMorgan Chase & Co. lifted their price target on Envista from $22.00 to $24.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Five research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $26.64.

Several hedge funds have recently modified their holdings of NVST. US Bancorp DE acquired a new position in shares of Envista in the 4th quarter valued at about $159,000. Victory Capital Management Inc. purchased a new position in shares of Envista in the 4th quarter valued at about $815,000. New York State Common Retirement Fund purchased a new position in shares of Envista in the 4th quarter valued at about $891,000. Rhumbline Advisers purchased a new position in shares of Envista in the 4th quarter valued at about $3,754,000. Finally, State Street Corp purchased a new position in shares of Envista in the 4th quarter valued at about $44,878,000.

NVST stock traded up $0.48 on Thursday, hitting $20.98. 25,766 shares of the company’s stock were exchanged, compared to its average volume of 3,242,121. Envista has a 12-month low of $10.08 and a 12-month high of $33.30. The firm has a 50 day moving average price of $19.78 and a two-hundred day moving average price of $23.05.

About Envista

Envista Holdings Corporation manufactures and sells dental products in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Ormco, Insignia, AOA, and Spark brands.

Featured Story: What is the Current Ratio?

Get a free copy of the Zacks research report on Envista (NVST)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Envista (NASDAQ:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.